文献速递衰弱、肌少症与跌倒老年综合评估

腕戴设备评估的衰弱可预测中年和老年人的住院与死亡:英国生物银行研究

Frailty assessed by a wrist-worn device can predict hospitalisation and mortality in middle-aged and older adults: a UK Biobank study.
PubMed 文献 · Age Ageing · 2025-01-01

调整混杂后,DGB衰弱与Fried衰弱均预测住院和死亡,且DGB衰弱在预测住院与死亡方面不劣于Fried衰弱表型。

要点

  • 腕戴设备提取的DGB衰弱可预测住院和死亡,且不劣于Fried衰弱表型。
  • DGB衰弱预测住院的HR为1.33(95%CI 1.17-1.52),Fried为1.29(1.13-1.47)。
  • DGB衰弱预测死亡的HR为1.77(95%CI 1.14-2.74),Fried为1.63(1.01-2.62)。

核心结论

  • DGB来源的衰弱可预测住院和死亡,且不劣于Fried衰弱表型。
  • 研究支持可穿戴设备在临床实践中评估衰弱的临床效度和潜在用途。

研究设计与样本

  • DGB通过验证算法从7天腕戴加速度计原始数据中提取,并据此衍生DGB衰弱。
  • 随访首次住院4.4±2.7年、死亡7.2±0.7年。

主要发现

  • 随访期间6148人(60.5%)住院(44 277人年随访),270人(2.7%)死亡(73 312人年随访)。
  • 调整混杂后,Fried和DGB衰弱均预测住院,HR分别为1.29(95%CI 1.13-1.47)和1.33(95%CI 1.17-1.52)。
  • Fried和DGB衰弱均预测死亡,HR分别为1.63(95%CI 1.01-2.62)和1.77(95%CI 1.14-2.74)。
  • DGB衰弱减Fried衰弱的Harrell's C-index均值差及95%CI:住院0.000(-0.002至0.001),死亡0.002(-0.004至0.009),95%CI下限超过预设非劣效界值-0.1。

关键数值与推荐

  • 非劣效界值为Harrell's C-index均值差-0.1,住院和死亡的95%CI下限均超过该界值。

临床怎么用

  • 腕戴设备提取的DGB衰弱可作为临床实践中评估衰弱的简便工具,用于预测住院和死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Digital gait biomarkers (DGBs) from wrist-worn devices may offer a simple, convenient method for assessing frailty; however, their clinical validity has not been sufficiently verified. This study aimed to determine whether frailty assessed using DGBs is not inferior to the Fried frailty phenotype for predicting hospitalisation and mortality. METHODS: This longitudinal study included 10 156 adults (aged 43-81 years) with complete Fried frailty phenotype and DGB data from the UK Biobank. DGBs were extracted using validated algorithms on raw data from wrist-worn accelerometers over 7 days. DGB frailty was derived from DGBs and the Fried frailty phenotype. RESULTS: First hospitalisations and deaths were followed for 4.4 ± 2.7 and 7.2 ± 0.7 years, respectively. In these periods, 6148 (60.5%) were hospitalised (44 277 person-years follow-up) and 270 (2.7%) died (73 312 person-years follow-up). Cox proportional hazards models, adjusting for confounders, showed that both Fried and DGB frailties were predictive of hospitalisation (hazard ratios and 95% confidence intervals [CIs]: 1.29 [1.13-1.47] versus 1.33 [1.17-1.52]) and mortality (1.63 [1.01-2.62] versus 1.77 [1.14-2.74]). The mean differences (DGB frailty-Fried frailty) and 95% CIs in Harrell's C-index for hospitalisation and mortality were 0.000 [-0.002 to 0.001] and 0.002 [-0.004 to 0.009], respectively, with the lower limit of the 95% CIs exceeding the prespecified noninferiority margin (-0.1). CONCLUSION: DGB-derived frailty predicted hospitalisation and mortality and was not inferior to the Fried frailty phenotype. These findings support the clinical validity and potential utility of wearable devices in the assessment of frailty in clinical practice.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Osuka Y, Chan LLY, Brodie M, et al. Frailty assessed by a wrist-worn device can predict hospitalisation and mortality in middle-aged and older adults: a UK Biobank study. Age Ageing. 2025. PMID: 40748313. doi:10.1093/ageing/afaf210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。